During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two mo...
Singapore: Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could b...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...
A better flu drug is on its way. This new class of specific, mechanism-based anti-influenza drug works by preventing the...
Singapore: Medicago has granted Philip Morris Products (PMP) an exclusive license to develop, commercialize and manufact...
Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million...
Allied Healthcare Group's investment company, Coridon, which is led by Professor Ian Frazer, is in the process of develo...
Singapore: Duke University has received a grant of up to $2.9 million from the Bill & Melinda Gates Foundation to pr...
Singapore: Following successful first-in-man phase I and two phase IIa clinical studies with the oral formulation of fin...
Singapore: Pharmaceutical Product Development (PPD) has appointed Dr David Johnston as executive vice president of globa...
Singapore: Australia's Starpharma has secured grant of $548,000 from Australian Research Council (ARC) Linkage grant. St...
Singapore: Agenus presented phase III data for GlaxoSmithKline's (GSK) RTS,S malaria vaccine candidate, which contains A...
Singapore: Chinese scientists have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis (Mtb)....
Singapore: Sinovac Biotech, a leading provider of biopharmaceutical products in China, is conducting double-blinded, ran...
Singapore: Baxter International has initiated a voluntary recall of one lot of Nitroglycerin in 5 percent Dextrose Injec...
Singapore: Regular shots of influenza injections have the added benefit of reducing the risk of heart attacks in people ...
Singapore: Biolife Science's strategy of targeting the tumour-associated antigen HER-2/NEU has been the focus of a recen...
Bangalore: Ranbaxy is going to exit its Bangalore-based vaccine manufacturing company, Biovel, according to Business Sta...
